Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Two Considerations

The problem is that the BoD does not change---most have been here from the very start of the company. We have had a couple of good CEOs who have dared to venture from what the BoD seems to want from this company and they have been removed or have removed themselves when they saw that they were NOT going to be able to build the co. against the BoD's wishes

.

.

While it may appear that there is no change:

Executive Officers of the Registrant

Our executive officers and their ages as of May 31, 2001, were as follows:

Name Age Position and Offices
Richard G. Blum 70 Chief Executive Officer and President
Lowell W. Giffhorn 54 Executive Vice President and Chief Financial Officer
Miklos Korodi 63 Vice President Sales and Marketing
Serge Miller 53 Vice President Engineering
David Pohl 63 Vice President Administration and Secretary

.

.

As to any CEO, good, bad, or indifferent, the lack of any quantifiable and predictable revenue stream would frustrate their ability to move the company forward. By analogy, think as a partner as the non-executives, with yourself as the CEO and you want to plan a vacation for next year as well as moving to a better neighborhood.

Easy with the known quantity of a regular salary, but if you didn't know from one month to the next, let alone one year to the next how much will be available, if anything at all, how much more difficult is that, no matter what the partner wishes?

.

.

.

Be well

Share
New Message
Please login to post a reply